Literature DB >> 8141535

Antitumor agents: extravasation, management, and surgical treatment.

N Scuderi1, M G Onesti.   

Abstract

We discuss our experience with antineoplastic drug extravasation. Between December 1988 and December 1990, 40 patients with cytostatic extravasation with lesions of varying seriousness were observed. In these patients, whenever possible, depending on the amount of time that elapsed since the accident and on the severity of the lesion, conservative therapy was done. The procedure consisted of local injection of a considerable amount of saline solution (20-90 ml, depending on the site of extravasation) and topical occlusive applications of corticosteroids locally. In all patients this was sufficient to avoid tissue necrosis. Treatment of a few patients deviated from these procedures because surgery was performed that ranged from the simple excision of infiltrated tissue to a more complex procedure of free flaps. On the basis of our experience, we discuss the role of early surgery when preventive measures and drug therapy are insufficient because of drug effects at the tissue level. In this series we did not perform early surgery.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8141535

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  9 in total

1.  Scrotal pain and ulceration post HIPEC: a case report.

Authors:  Nazirul Hannan B Abdul Aziz; Weining Wang; Melissa Ching Ching Teo
Journal:  J Gastrointest Cancer       Date:  2015-03

Review 2.  Management of the extravasation of anti-neoplastic agents.

Authors:  J Boulanger; A Ducharme; A Dufour; S Fortier; K Almanric
Journal:  Support Care Cancer       Date:  2015-02-26       Impact factor: 3.603

3.  Determination of Extravasation Effects of Nal-Iri and Trabectedin and Evaluation of Treatment Options for Trabectedin Extravasation in a Preclinical Animal Model.

Authors:  Omar Keritam; Viktoria Juhasz; Christian Schöfer; Christiane Thallinger; Marie-Bernadette Aretin; Gernot Schabbauer; Johannes Breuss; Matthias Unseld; Pavel Uhrin
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

4.  Tissue distribution of epirubicin after severe extravasation in humans.

Authors:  Jakob Nedomansky; Werner Haslik; Ursula Pluschnig; Christoph Kornauth; Christine Deutschmann; Stefan Hacker; Günther G Steger; Rupert Bartsch; Robert M Mader
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-27       Impact factor: 3.333

5.  A Primer on the Acute Management of Intravenous Extravasation Injuries for the Plastic Surgeon.

Authors:  Connor Maly; Kenneth L Fan; Gary F Rogers; Benjamin Mitchell; June Amling; Kara Johnson; Laura Welch; Albert K Oh; Jerry W Chao
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-04-19

6.  Extravasational side effects of cytotoxic drugs: A preventable catastrophe.

Authors:  Jagdeep S Thakur; C G S Chauhan; Vijay K Diwana; Dayal C Chauhan; Anamika Thakur
Journal:  Indian J Plast Surg       Date:  2008-07

7.  Anthracycline extravasation injuries: management with dexrazoxane.

Authors:  Karin Jordan; Timo Behlendorf; Franziska Mueller; Hans-Joachim Schmoll
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

8.  Extravasation injuries in adults.

Authors:  S Al-Benna; C O'Boyle; J Holley
Journal:  ISRN Dermatol       Date:  2013-05-08

9.  Surgical intervention for paediatric infusion-related extravasation injury: a systematic review.

Authors:  Max Little; Sophie Dupré; Justin Conrad Rosen Wormald; Matthew Gardiner; Chris Gale; Abhilash Jain
Journal:  BMJ Open       Date:  2020-08-06       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.